FDA launches gen AI Elsa to support clinical, regulatory tasks | TechTarget

The FDA announced it will extend the rollout of its generative artificial intelligence platform, Elsa, agency-wide by June 30, 2025. The agency’s internal generative AI tool is intended to assist FDA personnel in performing tasks related to clinical protocol assessments, safety evaluations and internal workflow efficiencies.

Elsa was developed through collaboration between the FDA’s internal technology teams and leadership across multiple centers. It operates within a secure GovCloud…